Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.55 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.55 |
| ▸ | ENPEP | Q07075 | 11/20 | 0.37 |
| ▸ | ANPEP | P15144 | 4/20 | 0.36 |
| ▸ | CA4 | P22748 | 1/20 | 0.31 |
| ▸ | MMP2 | P08253 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cysteine SCHEMBL3749540 | 1.00 | PTGS1 (0.55) | PTGS1SLC7A11ENPEPANPEPCA4 | |
| Cysteine SCHEMBL5148993 | 0.94 | — | — | |
| Cysteine SCHEMBL9335155 | 0.94 | — | — | |
| Cysteine SCHEMBL5410178 | 0.94 | PTGS1 (0.55) | PTGS1SLC7A11ENPEPANPEPCA4 | |
| Cysteine SCHEMBL1067775 | 0.94 | PTGS1 (0.55) | PTGS1SLC7A11ENPEPANPEPCA4 | |
| Cysteine SCHEMBL23903319 | 0.94 | PTGS1 (0.55) | PTGS1SLC7A11ENPEPANPEPCA4 | |
| Cysteine SCHEMBL4119279 | 0.94 | PTGS1 (0.55) | PTGS1SLC7A11ENPEPANPEPCA4 | |
| Cysteine SCHEMBL4872171 | 0.94 | — | — | |
| Cysteine SCHEMBL5410181 | 0.94 | PTGS1 (0.55) | PTGS1SLC7A11ENPEPANPEPCA4 | |
| Cysteine SCHEMBL5046066 | 0.94 | PTGS1 (0.55) | PTGS1SLC7A11ENPEPANPEPCA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040105894-A1 | Trace Metals synergized copper nucleotides and copper glycosides for anti-aging and antiviral compositions | GUPTA SHYAM K (US) | 2004-06-03 | — | — | US | claimed |
| US-7834210-B2 | Hair loss prevention by natural amino acid and peptide complexes | BIODERM RESEARCH (US) | 2010-11-16 | — | — | US | disclosed |
| US-20090253668-A1 | Hair Loss Prevention by Natural Amino Acid and Peptide Complexes | BIODERM RESEARCH (US) | 2009-10-08 | — | — | US | disclosed |
| US-7572933-B2 | Skin and hair restoration by natural amino acid peptide complexes | BIODERM RESEARCH (US) | 2009-08-11 | — | — | US | disclosed |
| US-20080287536-A1 | Skin and Hair Restoration by Natural Amino Acid and Peptide Crown Complexes | BIODERM RESEARCH (US) | 2008-11-20 | — | — | US | disclosed |
| US-7427690-B2 | Multifunction “crown complexes” from amino acids and peptides for skin and hair restoration | BIODERM RESEARCH (US) | 2008-09-23 | — | — | US | disclosed |
| US-20080090297-A1 | Methods for determining the metal bioavailability of metal sources | NOVUS INTERNATIONAL INC. (US) | 2008-04-17 | — | — | US | disclosed |
| US-20070227399-A1 | COMPOSITIONS AND METHODS FOR THE PRESERVATION OF WOOD | NOVUS INTERNATIONAL INC. (US) | 2007-10-04 | — | — | US | disclosed |
| US-20070099886-A1 | Multifunction \"Crown Complexes\" from Amino Acids and Peptides for Skin and Hair Restoration | BIODERM RESEARCH (US) | 2007-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080287536-A1 | Skin and Hair Restoration by Natural Amino Acid and Peptide Crown Complexes | MMP17, MC1R, TYR | PTGS1 436/4885SLC7A11 1227/4885ENPEP 19/4885 |
| US-20090253668-A1 | Hair Loss Prevention by Natural Amino Acid and Peptide Complexes | MMP1, MMP17, MMP13 | PTGS1 1192/4885SLC7A11 870/4885ENPEP 9/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.